Rapport Therapeutics, Inc. (RAPP) Reports Q4 Loss of $0.72
Tweet
Share
E-mailGet Alerts RAPP Hot Sheet
Join SI Premium – FREE
Rapport Therapeutics, Inc. (NASDAQ: RAPP) reported Q4 EPS of ($0.72), versus $0.00 reported last year.
For earnings history and earnings-related data on Rapport Therapeutics, Inc. (RAPP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: striking Iranian targets near Strait of Hormuz
- Yext, Inc. (YEXT) Tops Q2 EPS by 4c
- Active options: AAPL NVDA TSLA MU AMZN META SPCX INTC MSFT ORCL
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
